Low-level quinolone-resistance in multi-drug resistant typhoid

Journal of the College of Physicians and Surgeons Pakistan

Volumn 18, Issue 1, 2008, Pages 13-16

  Mirza, Sajjad Hussain ^a,b   Khan, Mumtaz Ahmad ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

^b NONE   (Pakistan)

Author keywords

Low level quinolone resistance; Multi drug resistance; Nalidixic acid; Salmonella

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD SAMPLING; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISK DIFFUSION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PAKISTAN; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SCREENING TEST; TYPHOID FEVER;

ANTI-INFECTIVE AGENTS; ANTIMALARIALS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; NUCLEIC ACID SYNTHESIS INHIBITORS; PILOT PROJECTS; QUINIDINE; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 41049117079     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mirza SH. Multi-drug resistant typhoid: a global review. Infec Dis J 2005; 14:17-20.
2. Mirza SH, Kariuki S, Mamun KZ, Beeching NJ, Hart CA. Analysis of plasmid and chromosomal DNA of multi-drug resistant Salmonella enterica serovar typhi from Asia. J clin Microbiol 2000; 38:1449-52.
3. Ling J, Chau PY. Plasmid mediating resistance to chloramphenicol, trimethoperim and ampicillin in Salmonella typhi strains isolated in the Southeast Asia region. J Infect Dis 1984; 149:652.
4. Asna SM, Haq JA, Rahman MM. Nalidixic acid resistant Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin caused treatment failure; a report from Bangladesh. Jpn J Infect Dis 2003; 56:32-3.
5. Nath G, Tikoo A, Manocha H, Tripathi AK, Gulati AK. Drug resistance in Salmonella typhi in north India with special reference to ciprofloxacin. J Antimicrob Chemother 2000; 46:149-50.
6. Parry C, Wain J, Chinh NT, Vinh H, Farrar JJ. Quinolone resistant Salmonella typhi in Vietnam. Lancet 1998; 351:1289.
7. Murdoch DA, Banatvaia N, Bone A, Shoismatulloev BI, Ward LR, Threlfall EJ. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan. Lancet 1998; 351:339.
8. Kariuki S, Revathi G, Muyodi J, Mwituria J, Munyalo A, Mirza S, et al. Characterization of multi-drug resistant typhoid outbreaks in Kenya. J Clin Microbiol 2004; 42:1477-82.
9. Mermin JH, Villar R, Carpenter J, Roberts L, Samridden A, Gasanova L, et al. A massive epidemic of multi-drug resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis 1999; 179:1416-22.
10. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001; 7:337-41.
11. National Committee for Clinical Laboratory Standards. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne; PA: Natl Committee Clin Lab Stand; 2004.
12. Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multi-drug resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 2000, 44:1855-9.
13. Farooqi B, Shreeq F, Rizvi QK, Khurshid M, Ahmed N, Saddiqa A, et al. Plasmid mediated antibacterial resistance in Salmonella typhi. J Coll Physicians Surg Pak 2001; 11:107-9.
14. Butt T, Luqman M, Dawood MM, Karmat KA. Is antibiotic susceptibility of typhoid Salmonella changing? Pak Armed Forces Med J 2000; 50:2-5.
15. Karamat KA, Butt T, Abdul Hannan, Nasirul Islam, Hussian T, Qureshi AH, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46:48-54.
16. Chandel DS, Chaudhry R. Enteric fever treatment failures: a global concern. Emerg Infect Dis 2001; 7:762-3.
17. Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug resistant Salmonella enterica serotype paratyphi A in India. Emerg Infect Dis 2000; 6:420-1.
18. Aarestrup FM, Wiuff C, Molbak K, Threlfall EJ. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 2003; 47:827-9.
19. Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35:1265-8.
20. Threlfall EJ. Antimicrobial drug resistance in Salmonella: problems and perspectives in food and water-borne infections. FEMS microbiol Rev 2002; 26:141-8.
21. Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P. Detection of fluoroquinolone susceptibility in Salmonella and validation of nalidixic acid screening test. j Clin Microbiol 1999; 37:3572-7.